Dr. Ishac Nazy is an Associate Professor at McMaster University and serves as the Co-Director of the Michael G. DeGroote Centre for Transfusion Research. After obtaining a Bachelor’s degree in Physical Sciences from the University of Guelph in 1996, Dr. Nazy furthered his academic pursuits at McMaster University, where he completed both his Bachelor's and Ph.D. in Biochemistry in 1998 and 2005, respectively. His research seeks to understand the intricacies of disease mechanisms, with the goal of developing diagnostic tools and therapeutic approaches to improve the health and everyday lives of those affected by immune-mediated platelet disorders. This work primarily involves platelet disorders associated with increased clotting, such as heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP), as well as those involving bleeding, such as immune thrombocytopenia (ITP). Recently, Dr. Nazy has shifted his focus to vaccine-induced immune thrombotic thrombocytopenia (VITT), a newly identified disorder characterized by thrombocytopenia and clotting associated with adenoviral vector-based COVID-19 vaccines.
